Ventas (VTR) Stock Price
Ventas Price
Revenue has compounded at 14.9% per year over the past 19 years to 5.83 B USD. Earnings per share have declined at 4.4% per year over the last 19 years. Ventas's net margin stands at 4.3%, up from 1.3% several years earlier. Ventas currently offers a dividend yield of about 2.21%. The payout ratio is around 367% of earnings. The dividend has grown at 1.0% per year over the past 19 years. Analysts set a median price target of 99.00 USD, implying 13.9% above the current price. Of 27 analysts, 22 rate the stock a buy — an overall Buy consensus.
Ventas stock price
Ventas business model & stock analysis
Frequently asked questions about Ventas
Ventas Inc is a leading real estate investment trust (REIT) specializing in healthcare properties. The business model of Ventas Inc revolves around owning, operating, and acquiring a diversified portfolio of properties across the healthcare sector. Their primary focus is on leasing and managing healthcare facilities, including senior housing communities, medical offices, hospitals, and research centers. By providing essential real estate solutions to healthcare providers, Ventas Inc generates recurring rental income and long-term value for its shareholders. Through strategic investments and a commitment to innovation, Ventas Inc continues to contribute to the growth and development of the healthcare industry.
Ventas Inc is primarily active in the healthcare real estate sector.
Some of the main competitors of Ventas Inc in the market include Welltower Inc and HCP Inc.
Ventas Inc is a renowned company operating in the real estate investment trust (REIT) sector. Established in 1998 and headquartered in Chicago, Illinois, Ventas specializes in healthcare-related properties. They own and manage a diverse portfolio of premium healthcare facilities, including senior housing communities, medical office buildings, hospitals, and skilled nursing facilities. Ventas has played a pivotal role in transforming the healthcare real estate sector through its strategic acquisitions and investments. With a strong commitment to delivering exceptional care environments, Ventas Inc has become a leading name in the industry, offering investors an opportunity to participate in this thriving sector.
Some significant milestones achieved by Ventas Inc include becoming the first healthcare real estate investment trust (REIT) to be listed on the New York Stock Exchange in 1999. The company also expanded its portfolio through strategic acquisitions, such as the $7.2 billion merger with Nationwide Health Properties in 2011. Additionally, Ventas Inc consistently demonstrated strong financial performance, increasing its annual dividend for 19 consecutive years. The company's commitment to long-term growth and its focus on providing quality healthcare real estate solutions have made Ventas Inc a leader in the industry.
Ventas Inc is primarily present in the United States.
Ventas Inc represents a commitment to integrity, innovation, and excellence in the healthcare real estate industry. The company strives to enhance the lives of seniors and other patients by providing high-quality and transformative healthcare environments. With a focus on sustainable growth and generating long-term value for stakeholders, Ventas Inc employs a philosophy of collaboration, transparency, and ethical business practices. By consistently delivering innovative solutions and maintaining strong relationships with its tenants and partners, Ventas Inc continues to lead the way in the healthcare real estate sector.
Analysts currently set an average price target of 98.85 USD for the Ventas stock (median: 99.00 USD), implying +18.0 % versus the latest price. The consensus is based on 27 analyst ratings.
27 analysts currently rate the Ventas stock: 22 recommend buying, 5 holding and 0 selling. For 2026, analysts expect Ventas to generate revenue of 6.96 B USD and earnings per share of 0.56 USD.
Converted at the current exchange rate, the Ventas share trades at 77.12 EUR (86.91 USD).
The Ventas share (VTR) is listed on 7 stock exchanges, including: NYSE (VTR), London (0LO4.L), SIX (Zürich) (VEN.SW), Frankfurt (VEN.F), München (VEN.MU), Düsseldorf (VEN.DU).
Ventas Inc is a US-based company specializing in healthcare real estate investments. Its business model is based on acquiring and managing properties used by healthcare and senior living facilities. The company is divided into three business segments: Senior Housing Operating Portfolio (SHOP), Medical Office Buildings (MOB), and Life Science Properties (LSP). SHOP includes a wide range of nursing homes and elderly care facilities. Ventas Inc acquires these properties either through facility purchases or by acquiring concession contracts from operators. The company directly operates approximately 110 facilities, making SHOP its highest revenue-generating segment. The MOB segment focuses on acquiring properties used by medical facilities such as doctor's offices, laboratories, and surgical centers. These facilities are often located in complex buildings or campus-like environments and often offer services such as pharmacies, radiology, and rehabilitation. LSP focuses on the real estate needs of life science companies, including biopharmaceutical, biotechnology, and diagnostic companies. The complexity of the properties developed for life science companies requires a high level of expertise and flexibility. Ventas Inc also provides financing and capital structures for the development or acquisition of properties in the SHOP, MOB, and LSP segments. These financing offerings can be tailored to the specific needs of facilities and operators and also include partnerships with other investors. Ventas Inc strives to ensure high-quality and continuous care for patients in its healthcare market through the provision of real estate and financing. The company also emphasizes a long-term growth strategy focused on strengthening operational performance and financial metrics. Overall, Ventas Inc's business model demonstrates a consistent focus on the increasingly important healthcare industry and the needs of patients. With a wide range of real estate offerings and financing options, the company is well-positioned to drive industry growth.
The expected revenue of Ventas is 6.96 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Ventas is 269.63 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Ventas is currently 154.97. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Ventas stock.
The price-to-sales ratio (P/S) of Ventas is currently 6.01. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Ventas stock.
The Eulerpool Quality Score for Ventas is 4/10.
The ISIN of Ventas is US92276F1003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Ventas is 878380. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Ventas is VTR. The ticker symbol is used to trade Ventas shares on the stock exchange.
Ventas stock
Ventas Peer Group
Ventas Ticker
Ventas FIGI
All fundamentals and in-depth analysis of Ventas
Our stock analysis for Ventas stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ventas. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.